BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37899744)

  • 1. Licochalcone H Targets EGFR and AKT to Suppress the Growth of Oxaliplatin -Sensitive and -Resistant Colorectal Cancer Cells.
    Lee SO; Lee MH; Kwak AW; Lee JY; Yoon G; Joo SH; Choi YH; Park JW; Shim JH
    Biomol Ther (Seoul); 2023 Nov; 31(6):661-673. PubMed ID: 37899744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Licochalcone C Inhibits the Growth of Human Colorectal Cancer HCT116 Cells Resistant to Oxaliplatin.
    Lee SO; Joo SH; Lee JY; Kwak AW; Kim KT; Cho SS; Yoon G; Choi YH; Park JW; Shim JH
    Biomol Ther (Seoul); 2024 Jan; 32(1):104-114. PubMed ID: 38148556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolinderalactone sensitizes oxaliplatin-resistance colorectal cancer cells through JNK/p38 MAPK signaling pathways.
    Kwak AW; Park JW; Lee SO; Lee JY; Seo JH; Yoon G; Lee MH; Choi JS; Shim JH
    Phytomedicine; 2022 Oct; 105():154383. PubMed ID: 35987016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Licochalcone B inhibits growth and induces apoptosis of human non-small-cell lung cancer cells by dual targeting of EGFR and MET.
    Oh HN; Lee MH; Kim E; Yoon G; Chae JI; Shim JH
    Phytomedicine; 2019 Oct; 63():153014. PubMed ID: 31323446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Licochalcone H Synthesized by Modifying Structure of Licochalcone C Extracted from Glycyrrhiza inflata Induces Apoptosis of Esophageal Squamous Cell Carcinoma Cells.
    Kwak AW; Cho SS; Yoon G; Oh HN; Lee MH; Chae JI; Shim JH
    Cell Biochem Biophys; 2020 Mar; 78(1):65-76. PubMed ID: 31707583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
    Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
    Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licochalcone B Induces ROS-Dependent Apoptosis in Oxaliplatin-Resistant Colorectal Cancer Cells via p38/JNK MAPK Signaling.
    Kwak AW; Kim WK; Lee SO; Yoon G; Cho SS; Kim KT; Lee MH; Choi YH; Lee JY; Park JW; Shim JH
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Licochalcone H Induces Cell Cycle Arrest and Apoptosis in Human Skin Cancer Cells by Modulating JAK2/STAT3 Signaling.
    Park KH; Joo SH; Seo JH; Kim J; Yoon G; Jeon YJ; Lee MH; Chae JI; Kim WK; Shim JH
    Biomol Ther (Seoul); 2022 Jan; 30(1):72-79. PubMed ID: 34873073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licochalcone D Induces ROS-Dependent Apoptosis in Gefitinib-Sensitive or Resistant Lung Cancer Cells by Targeting EGFR and MET.
    Oh HN; Lee MH; Kim E; Kwak AW; Yoon G; Cho SS; Liu K; Chae JI; Shim JH
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32070026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echinatin induces reactive oxygen species-mediated apoptosis via JNK/p38 MAPK signaling pathway in colorectal cancer cells.
    Kwak AW; Lee JY; Lee SO; Seo JH; Park JW; Choi YH; Cho SS; Yoon G; Lee MH; Shim JH
    Phytother Res; 2023 Feb; 37(2):563-577. PubMed ID: 36184899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Associated Macrophages Promote Oxaliplatin Resistance
    Lan H; Liu Y; Liu J; Wang X; Guan Z; Du J; Jin K
    Mol Pharm; 2021 Mar; 18(3):1026-1037. PubMed ID: 33555197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.
    Xu R; Yin J; Zhang Y; Zhang S
    J Cell Biochem; 2019 Sep; 120(9):14585-14593. PubMed ID: 30998268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
    Cheraghi-Shavi T; Jalal R; Minuchehr Z
    PLoS One; 2023; 18(8):e0289535. PubMed ID: 37535601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells.
    Gao F; Li M; Yu X; Liu W; Zhou L; Li W
    J Cell Mol Med; 2021 Jan; 25(2):813-826. PubMed ID: 33247550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berbamine dihydrochloride suppresses the progression of colorectal cancer via RTKs/Akt axis.
    Liu L; Liang D; Zheng Q; Zhao M; Lv R; Tang J; Chen N
    J Ethnopharmacol; 2023 Mar; 303():116025. PubMed ID: 36496042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Licochalcone H induces the apoptosis of human oral squamous cell carcinoma cells via regulation of matrin 3.
    Nho SH; Yoon G; Seo JH; Oh HN; Cho SS; Kim H; Choi HW; Shim JH; Chae JI
    Oncol Rep; 2019 Jan; 41(1):333-340. PubMed ID: 30320347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel exosomal miR-46146 transfer oxaliplatin chemoresistance in colorectal cancer.
    Xu Y; Zhu M
    Clin Transl Oncol; 2020 Jul; 22(7):1105-1116. PubMed ID: 31728833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-erythroid 2-related factor 3 (NRF3) is low expressed in colorectal cancer and its down-regulation promotes colorectal cancer malignance through activating EGFR and p38/MAPK.
    Zhou S; Li Y; Lu J; Chen C; Wang W; Wang L; Zhang Z; Dong Z; Tang F
    Am J Cancer Res; 2019; 9(3):511-528. PubMed ID: 30949407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.